GlaxoSmithKline Plc (Mexico) Technical Analysis

GSKN Stock  MXN 655.00  51.98  7.35%   
As of the 19th of April, GlaxoSmithKline Plc retains the risk adjusted performance of 0.04, and Market Risk Adjusted Performance of 0.4497. GlaxoSmithKline Plc technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate twelve technical drivers for GlaxoSmithKline plc, which can be compared to its competitors. Please check out GlaxoSmithKline plc market risk adjusted performance, coefficient of variation, variance, as well as the relationship between the mean deviation and standard deviation to decide if GlaxoSmithKline Plc is priced fairly, providing market reflects its last-minute price of 655.0 per share.

GlaxoSmithKline Plc Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as GlaxoSmithKline, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GlaxoSmithKline
  
GlaxoSmithKline Plc's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
GlaxoSmithKline Plc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of GlaxoSmithKline Plc technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of GlaxoSmithKline Plc trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

GlaxoSmithKline plc Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of GlaxoSmithKline plc volatility. High ATR values indicate high volatility, and low values indicate low volatility.

GlaxoSmithKline plc Trend Analysis

Use this graph to draw trend lines for GlaxoSmithKline plc. You can use it to identify possible trend reversals for GlaxoSmithKline Plc as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual GlaxoSmithKline Plc price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

GlaxoSmithKline Plc Best Fit Change Line

The following chart estimates an ordinary least squares regression model for GlaxoSmithKline plc applied against its price change over selected period. The best fit line has a slop of   0.05  , which means GlaxoSmithKline plc will continue generating value for investors. It has 122 observation points and a regression sum of squares at 113.24, which is the sum of squared deviations for the predicted GlaxoSmithKline Plc price change compared to its average price change.

About GlaxoSmithKline Plc Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of GlaxoSmithKline plc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of GlaxoSmithKline plc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on GlaxoSmithKline plc price pattern first instead of the macroeconomic environment surrounding GlaxoSmithKline plc. By analyzing GlaxoSmithKline Plc's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of GlaxoSmithKline Plc's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to GlaxoSmithKline Plc specific price patterns or momentum indicators. Please read more on our technical analysis page.

GlaxoSmithKline Plc April 19, 2024 Technical Indicators

Most technical analysis of GlaxoSmithKline help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for GlaxoSmithKline from various momentum indicators to cycle indicators. When you analyze GlaxoSmithKline charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline Plc's price analysis, check to measure GlaxoSmithKline Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline Plc is operating at the current time. Most of GlaxoSmithKline Plc's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline Plc's price. Additionally, you may evaluate how the addition of GlaxoSmithKline Plc to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Please note, there is a significant difference between GlaxoSmithKline Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.